Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Robert Paradiso
A deep dive into patent law and exclusivity in the United States
Introduction The pharmaceutical industry is critical to the progress of science in researching, developing and introducing new therapies that improve the health and quality of life for patients around the globe. This continued progress requires an extensive amount of funding and financial risk due to the complexity and unpredictability of basic research, clinical trials and the approval process, which result in many failed drugs for every success.
How ex parte re-examination is becoming a primary risk management tool
5 min read | | As IPR access becomes less predictable, reexams are in vogue but come with significant trade-offs Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts. Subscribe now Already have access?
12.18.25 -- Top 10 Of 2025
BEST OF INDUSTRY INSIGHTS Connect With Outsourced Pharma:
08.29.25 -- Hybrid. Continuous. Peptide. Manufacturing. Lilly's Put It All Together.
Explore the future of pharmaceutical packaging in this webinar from Adare Pharma Solutions. Discover how patient-centric designs, advanced safety systems, and sustainable materials are improving adherence and enabling innovative therapies. Learn how automation, digitalization, and regulatory guidance are reshaping packaging operations. Gain exclusive insights into trends, technologies, and partner selection strategies that will define the next decade—register today! Click here to learn more.
Navigating Contract Manufacturing Agreements: Tips And Pitfalls For Pharma And Biopharma Companies
The manufacture of pharmaceutical and biologic products requires an enormous amount of funding and logistics in order to ramp up and maintain production. If a company seeks to keep the manufacturing in-house, it will need to adequately address requirements such as real estate, facilities, and human resources, as well as meeting quality assurance and all legal and regulatory requirements.
Navigating Contract Manufacturing Agreements: Tips And Pitfalls For Pharma And Biopharma Companies
By Robert Paradiso, partner, Lowenstein Sandler LLP The manufacture of pharmaceutical and biologic products requires an enormous amount of funding and logistics in order to ramp up and maintain production. If a company seeks to keep the manufacturing in-house, it will need to adequately address requirements such as real estate, facilities, and human resources, as well as meeting quality assurance and all legal and regulatory requirements.
A deep dive into patent law and exclusivity in the United States
Introduction The pharmaceutical industry is critical to the progress of science in researching, developing and introducing new therapies that improve the health and quality of life for patients around the globe. This continued progress requires an extensive amount of funding and financial risk due to the complexity and unpredictability of basic research, clinical trials and the approval process, which result in many failed drugs for every success.
The Future Of Cancer Drug Development: Advancements, Challenges, And The Transformative Role Of AI
The landscape of cancer research and drug development is constantly evolving, with groundbreaking advancements shaping the future of oncology treatments. Understanding not only the science but the regulatory concerns, legal challenges, and market climate for this industry is critical. One of the most significant changes in recent years has been the introduction of artificial intelligence (AI) to drug research and development.
A Deep Dive Into Patent Law And Exclusivity In The United States
The pharmaceutical industry is critical to the progress of science in researching, developing and introducing new therapies that improve the health and quality of life for patients around the globe. This continued progress requires an extensive amount of funding and financial risk due to the complexity and unpredictability of basic research, clinical trials and the approval process, which result in many failed drugs for every success.
IP experts remain positive in the face of changes to the global life sciences landscape
Contributors to the latest edition of the IAM Guide to Life Sciences stress that, while AI has the potential to revolutionise the global life sciences landscape, its integration in the pharma industry and the growing threat of cybersecurity breaches pose significant challenges to those operating in this space. However, there are many opportunities of which rights holders can take advantage.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Robert
Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack